{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:13Z","timestamp":1786984333126,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.amjcard.2015.12.027","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T21:46:34Z","timestamp":1451425594000},"page":"926-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation"],"prefix":"10.1016","volume":"117","author":[{"given":"Shuang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-5416","authenticated-orcid":false,"given":"Yan-min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-bin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.12.027_bib1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1540-8167.2002.00764.x","article-title":"Cerebrovascular complication associated with pulmonary vein ablation","volume":"13","author":"Kok","year":"2002","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijcard.2015.03.376","article-title":"Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation","volume":"187","author":"Nairooz","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","article-title":"Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation","volume":"6","author":"Bassiouny","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10840-013-9793-7","article-title":"Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter","volume":"37","author":"Kaiser","year":"2013","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/pace.12401","article-title":"Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study","volume":"37","author":"Arshad","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib6","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/pace.12195","article-title":"The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran","volume":"36","author":"Ichiki","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1253\/circj.CJ-12-0498","article-title":"Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation","volume":"76","author":"Kaseno","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2015.12.027_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40261-013-0081-1","article-title":"Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation","volume":"33","author":"Yamaji","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.amjcard.2015.12.027_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hrthm.2012.12.011","article-title":"Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation","volume":"10","author":"Kim","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10840-014-9888-9","article-title":"Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation","volume":"40","author":"Stepanyan","year":"2014","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib12","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.1016\/S0735-1097(13)60276-4","article-title":"Comparison of atrial fibrillation ablation bleeding and thrombotic complications with dabigatran, rivaroxaban and warfarin","volume":"61","author":"Bernard","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib13","first-page":"S236","article-title":"The safety of dabigatran versus warfarin in patients undergoing atrial fibrillation ablation","volume":"10","author":"Garcia","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib14","first-page":"30","article-title":"Discontinuation period and periprocedural events of novel oral anticoagulation in patients undergoing catheter ablation of atrial fibrillation","volume":"35","author":"Hirose","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.12.027_bib15","first-page":"S260","article-title":"Novel oral anticoagulants reduces preprocedural anticoagulation duration, but increases intra-procedural heparin requirement compared to uninterrupted warfarin in atrial fibrillation catheter ablation","volume":"12","author":"Shin","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib16","first-page":"S310","article-title":"Relationship between oral anticoagulants and dose of heparin during procedure in patients undergoing catheter ablation of atrial fibrillation","volume":"11","author":"Toyama","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/circ.130.suppl_2.16402","article-title":"Feasibility and safety of uninterrupted rivaroxaban in patients undergoing radiofrequency ablation for long standing persistent atrial fibrillation","volume":"130","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.12.027_bib18","first-page":"iii234","article-title":"Ablation of atrial fibrillation with uninterrupted NOAC treatment during ablation of atrial fibrillation is not associated with severe peri- and postprocedural complications","volume":"17","author":"Wunderlich","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2015.12.027_bib19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","article-title":"Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study","volume":"12","author":"Di Biase","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib20","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.12.027_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCEP.114.001586","article-title":"Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures","volume":"7","author":"Dillier","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2014.10.005","article-title":"Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon","volume":"115","author":"Kaess","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","article-title":"Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"63","author":"Lakkireddy","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/jce.12143","article-title":"Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation","volume":"24","author":"Maddox","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.hrthm.2015.04.016","article-title":"Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation","volume":"12","author":"Nagao","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.12.027_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pace.12553","article-title":"Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation","volume":"38","author":"Nagao","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2169\/internalmedicine.54.3520","article-title":"Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation","volume":"54","author":"Nagao","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.amjcard.2015.12.027_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11239-013-0958-0","article-title":"Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal","volume":"37","author":"Jackson Ii","year":"2014","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2015.12.027_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.amjcard.2013.12.027","article-title":"Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation","volume":"113","author":"Sardar","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.027_bib30","doi-asserted-by":"crossref","first-page":"e0126512","DOI":"10.1371\/journal.pone.0126512","article-title":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis","volume":"10","author":"Santarpia","year":"2015","journal-title":"PLoS One"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915300722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915300722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T23:21:57Z","timestamp":1653952917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915300722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002914915300722"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}